IL143092A0 - Stabilization of macrolides - Google Patents
Stabilization of macrolidesInfo
- Publication number
- IL143092A0 IL143092A0 IL14309299A IL14309299A IL143092A0 IL 143092 A0 IL143092 A0 IL 143092A0 IL 14309299 A IL14309299 A IL 14309299A IL 14309299 A IL14309299 A IL 14309299A IL 143092 A0 IL143092 A0 IL 143092A0
- Authority
- IL
- Israel
- Prior art keywords
- macrolides
- stabilization
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9826882.4A GB9826882D0 (en) | 1998-12-07 | 1998-12-07 | Organic compounds |
GBGB9904934.8A GB9904934D0 (en) | 1998-12-07 | 1999-03-04 | Organic compounds |
PCT/EP1999/009521 WO2000033878A2 (en) | 1998-12-07 | 1999-12-06 | Stabilization of macrolides |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143092A0 true IL143092A0 (en) | 2002-04-21 |
Family
ID=26314797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14309299A IL143092A0 (en) | 1998-12-07 | 1999-12-06 | Stabilization of macrolides |
Country Status (38)
Country | Link |
---|---|
US (5) | US6605613B2 (it) |
EP (4) | EP1137439B2 (it) |
JP (3) | JP3805625B2 (it) |
KR (2) | KR20060096477A (it) |
CN (2) | CN1261163C (it) |
AR (3) | AR026102A1 (it) |
AT (1) | ATE365051T1 (it) |
AU (1) | AU759219B2 (it) |
BE (1) | BE1012869A3 (it) |
BR (1) | BR9915986A (it) |
CA (3) | CA2651609A1 (it) |
CO (1) | CO4980847A1 (it) |
CY (1) | CY1106870T1 (it) |
CZ (2) | CZ303006B6 (it) |
DE (1) | DE69936352T3 (it) |
DK (1) | DK1137439T4 (it) |
ES (1) | ES2288033T5 (it) |
FR (1) | FR2786771B1 (it) |
GB (2) | GB9826882D0 (it) |
HK (1) | HK1038889B (it) |
HU (2) | HU230174B1 (it) |
ID (1) | ID29250A (it) |
IL (1) | IL143092A0 (it) |
IT (1) | IT1319701B1 (it) |
MY (2) | MY127579A (it) |
NO (2) | NO332698B1 (it) |
NZ (2) | NZ511936A (it) |
PE (1) | PE20001333A1 (it) |
PL (2) | PL208854B1 (it) |
PT (1) | PT1137439E (it) |
RU (1) | RU2243769C2 (it) |
SG (1) | SG151072A1 (it) |
SI (1) | SI1137439T2 (it) |
SK (2) | SK287325B6 (it) |
TR (2) | TR200201428T2 (it) |
TW (2) | TWI248938B (it) |
WO (1) | WO2000033878A2 (it) |
ZA (1) | ZA200104360B (it) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
WO2003068980A2 (en) | 2002-02-13 | 2003-08-21 | Biogal Gyogyszergyar Rt | Method for extracting a macrolide from biomatter |
US7452692B2 (en) | 2002-02-13 | 2008-11-18 | Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Method for extracting a macrolide from biomatter |
CN100402031C (zh) | 2002-07-30 | 2008-07-16 | 惠氏公司 | 含有瑞帕霉素羟基酯的胃肠外制剂 |
TR200500302T3 (tr) | 2003-03-31 | 2005-04-21 | Biogal Gyogyszergyar Rt. | Makrolidlerin kristalizasyonu ve saflaştırılması. |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
ATE378345T1 (de) | 2003-07-24 | 2007-11-15 | Teva Gyogyszergyar Zartkoeruee | Verfahren zur aufreinigung von makroliden |
US9114198B2 (en) * | 2003-11-19 | 2015-08-25 | Advanced Cardiovascular Systems, Inc. | Biologically beneficial coatings for implantable devices containing fluorinated polymers and methods for fabricating the same |
WO2005056103A1 (en) * | 2003-12-10 | 2005-06-23 | Acrux Dds Pty Ltd | Method of treatment for undesired effect following transdermal or topical drug delivery |
US8551512B2 (en) | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
CN101076319A (zh) * | 2004-09-29 | 2007-11-21 | 科迪斯公司 | 稳定的非晶形雷帕霉素样化合物的药物剂型 |
BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
AR058283A1 (es) * | 2005-12-07 | 2008-01-30 | Wyeth Corp | Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido |
US7700614B2 (en) * | 2005-12-14 | 2010-04-20 | Abbott Laboratories | One pot synthesis of tetrazole derivatives of rapamycin |
AU2006331874A1 (en) * | 2005-12-20 | 2007-07-05 | Wyeth | Control of CCI-779 dosage form stability through control of drug substance impurities |
KR20140093764A (ko) * | 2006-02-09 | 2014-07-28 | 산텐 세이야꾸 가부시키가이샤 | 안정한 제제와 그 제조 및 사용 방법 |
CN103127100A (zh) | 2006-03-23 | 2013-06-05 | 参天制药株式会社 | 用于与血管通透性有关的疾病或病症的制剂和方法 |
JP2013527223A (ja) | 2010-06-02 | 2013-06-27 | フレゼニウス・カビ・オンコロジー・リミテッド | ラパマイシンエステルの安定な医薬組成物 |
CA2797501A1 (en) * | 2010-06-07 | 2011-12-15 | Telik, Inc. | Crystalline ezatiostat hydrochloride ansolvate |
CN103140494A (zh) * | 2010-08-04 | 2013-06-05 | 美利奴生命科学有限公司 | 制备具有抗增殖特性的新的42-o-(杂烷氧基烷基)雷帕霉素化合物的方法 |
WO2012066502A1 (en) | 2010-11-19 | 2012-05-24 | Biocon Limited | Processes for preparation of everolimus and intermediates thereof |
EP2717884A1 (en) | 2011-06-06 | 2014-04-16 | Chevron Phillips Chemical Company LP | Use of metallocene compounds for cancer treatment |
WO2013022201A1 (en) * | 2011-08-11 | 2013-02-14 | Dong-A Pharm. Co., Ltd. | Process of preparing a stabilized and solubilized formulation of sirolimus derivatives |
US9610385B2 (en) | 2013-03-07 | 2017-04-04 | Abbott Cardiovascular Systems Inc. | Method of fabricating an implantable medical device comprising a rapamycin derivative |
IN2013MU02532A (it) | 2013-07-31 | 2015-06-26 | Sahajanand Medical Technologies Pvt Ltd | |
CN104721158B (zh) * | 2013-12-24 | 2018-01-30 | 正大天晴药业集团股份有限公司 | 一种稳定的依维莫司片剂 |
CN104892632B (zh) * | 2015-06-03 | 2017-12-26 | 道中道(菏泽)制药有限公司 | 一种晶体形式的依维莫司及其制备方法 |
US10383860B2 (en) | 2015-07-28 | 2019-08-20 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical composition comprising rapamycin or derivative thereof, and method for producing the same |
EP3342410A4 (en) * | 2015-08-28 | 2019-04-24 | Nippon Kayaku Kabushiki Kaisha | PHARMACEUTICAL COMPOSITION WITH RAPAMYCIN OR DERIVATIVES THEREOF |
JP7020914B2 (ja) * | 2015-09-18 | 2022-02-16 | 日本化薬株式会社 | ラパマイシン又はその誘導体を含有する医薬組成物 |
WO2017129772A1 (en) | 2016-01-29 | 2017-08-03 | Xellia Phamaceuticals Aps | Stable pharmaceutical compositions of temsirolimus |
EP3466424A1 (en) | 2016-05-27 | 2019-04-10 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical composition comprizing rapamycin or derivative thereof |
KR102051806B1 (ko) * | 2018-01-12 | 2019-12-04 | 주식회사 종근당 | 에베로리무스를 포함하는 안정화된 약제학적 제제 |
JP2023519875A (ja) | 2020-03-27 | 2023-05-15 | ボストン サイエンティフィック サイムド,インコーポレイテッド | 薬品の結晶化のための方法 |
JP2023028473A (ja) * | 2021-08-19 | 2023-03-03 | 日本マイクロバイオファーマ株式会社 | エベロリムスの製造方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) * | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
US3996355A (en) | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
US4049128A (en) | 1976-11-18 | 1977-09-20 | Westinghouse Air Brake Company | Control system for automatic railway car coupler |
AU543727B2 (en) * | 1980-06-02 | 1985-05-02 | Ayerst Mckenna & Harrison Inc. | Injectable composition of rapamycin |
JPH01249651A (ja) † | 1988-02-18 | 1989-10-04 | E I Du Pont De Nemours & Co | セラミツク/蒸留可能な結合剤組成物 |
GB8803836D0 (en) | 1988-02-18 | 1988-03-16 | Glaxo Group Ltd | Compositions |
KR0159766B1 (ko) * | 1989-10-16 | 1998-12-01 | 후지사와 토모키치로 | 양모제 조성물 |
JPH04230389A (ja) | 1990-07-16 | 1992-08-19 | American Home Prod Corp | ラパマイシン誘導体 |
JP3108192B2 (ja) * | 1991-05-07 | 2000-11-13 | アメリカン・ホーム・プロダクツ・コーポレイション | 免疫抑制剤、抗炎症剤または抗真菌剤用ラパマイシンの還元生成物 |
GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
US5302584A (en) * | 1992-10-13 | 1994-04-12 | American Home Products Corporation | Carbamates of rapamycin |
DK0593227T3 (da) | 1992-10-13 | 2006-05-01 | Wyeth Corp | Carbamater af rapamycin |
KR100400620B1 (ko) * | 1995-06-09 | 2004-02-18 | 노파르티스 아게 | 라파마이신유도체 |
FR2736550B1 (fr) * | 1995-07-14 | 1998-07-24 | Sandoz Sa | Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule |
NZ333657A (en) * | 1996-07-30 | 2000-05-26 | Novartis Ag | A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin |
US6362264B1 (en) * | 1996-12-20 | 2002-03-26 | Ck Witco Corporation | Stabilizer for food contact and medical grade PVC |
EP0975330A1 (en) | 1997-02-04 | 2000-02-02 | Abbott Laboratories | Pain reducing parenteral liposome formulation |
-
1998
- 1998-12-07 GB GBGB9826882.4A patent/GB9826882D0/en not_active Ceased
-
1999
- 1999-03-04 GB GBGB9904934.8A patent/GB9904934D0/en not_active Ceased
- 1999-11-29 CO CO99074905A patent/CO4980847A1/es unknown
- 1999-12-02 IT IT1999MI002520A patent/IT1319701B1/it active
- 1999-12-03 PE PE1999001209A patent/PE20001333A1/es not_active IP Right Cessation
- 1999-12-03 FR FR9915256A patent/FR2786771B1/fr not_active Expired - Lifetime
- 1999-12-03 AR ARP990106171A patent/AR026102A1/es active IP Right Grant
- 1999-12-04 TW TW088121250A patent/TWI248938B/zh not_active IP Right Cessation
- 1999-12-04 TW TW094104943A patent/TWI270550B/zh not_active IP Right Cessation
- 1999-12-06 ID IDW00200101156A patent/ID29250A/id unknown
- 1999-12-06 BR BR9915986-4A patent/BR9915986A/pt not_active Application Discontinuation
- 1999-12-06 AT AT99959381T patent/ATE365051T1/de active
- 1999-12-06 HU HU1300289A patent/HU230174B1/hu unknown
- 1999-12-06 DE DE69936352T patent/DE69936352T3/de not_active Expired - Lifetime
- 1999-12-06 SK SK5032-2008A patent/SK287325B6/sk not_active IP Right Cessation
- 1999-12-06 CN CNB998141240A patent/CN1261163C/zh not_active Expired - Lifetime
- 1999-12-06 EP EP99959381A patent/EP1137439B2/en not_active Expired - Lifetime
- 1999-12-06 HU HU0104489A patent/HU228939B1/hu unknown
- 1999-12-06 IL IL14309299A patent/IL143092A0/xx not_active IP Right Cessation
- 1999-12-06 DK DK99959381.7T patent/DK1137439T4/da active
- 1999-12-06 CA CA002651609A patent/CA2651609A1/en not_active Abandoned
- 1999-12-06 CZ CZ20012001A patent/CZ303006B6/cs not_active IP Right Cessation
- 1999-12-06 JP JP2000586368A patent/JP3805625B2/ja not_active Expired - Lifetime
- 1999-12-06 RU RU2001118266/15A patent/RU2243769C2/ru active
- 1999-12-06 AU AU16573/00A patent/AU759219B2/en not_active Expired
- 1999-12-06 SK SK766-2001A patent/SK286688B6/sk not_active IP Right Cessation
- 1999-12-06 CA CA2732620A patent/CA2732620C/en not_active Expired - Lifetime
- 1999-12-06 WO PCT/EP1999/009521 patent/WO2000033878A2/en active Application Filing
- 1999-12-06 TR TR2002/01428T patent/TR200201428T2/xx unknown
- 1999-12-06 KR KR1020067017352A patent/KR20060096477A/ko not_active Application Discontinuation
- 1999-12-06 CN CN2006100798040A patent/CN1876657B/zh not_active Expired - Lifetime
- 1999-12-06 SG SG200302502-0A patent/SG151072A1/en unknown
- 1999-12-06 EP EP06122628A patent/EP1743657A3/en not_active Ceased
- 1999-12-06 CZ CZ20050170A patent/CZ302210B6/cs not_active IP Right Cessation
- 1999-12-06 NZ NZ511936A patent/NZ511936A/en not_active IP Right Cessation
- 1999-12-06 ES ES99959381T patent/ES2288033T5/es not_active Expired - Lifetime
- 1999-12-06 PL PL380082A patent/PL208854B1/pl unknown
- 1999-12-06 KR KR1020017007009A patent/KR100695834B1/ko active IP Right Grant
- 1999-12-06 CA CA2351580A patent/CA2351580C/en not_active Expired - Lifetime
- 1999-12-06 TR TR2001/01416T patent/TR200101416T2/xx unknown
- 1999-12-06 SI SI9930985T patent/SI1137439T2/sl unknown
- 1999-12-06 EP EP10179099A patent/EP2269651A3/en not_active Withdrawn
- 1999-12-06 EP EP10179096A patent/EP2279751A3/en not_active Withdrawn
- 1999-12-06 PL PL348333A patent/PL196627B1/pl unknown
- 1999-12-06 PT PT99959381T patent/PT1137439E/pt unknown
- 1999-12-07 MY MYPI20043386A patent/MY127579A/en unknown
- 1999-12-07 MY MYPI99005309A patent/MY120594A/en unknown
- 1999-12-07 BE BE9900799A patent/BE1012869A3/fr not_active IP Right Cessation
-
2001
- 2001-05-16 NO NO20012424A patent/NO332698B1/no not_active IP Right Cessation
- 2001-05-28 ZA ZA200104360A patent/ZA200104360B/en unknown
- 2001-05-29 US US09/866,977 patent/US6605613B2/en not_active Expired - Lifetime
-
2002
- 2002-01-28 HK HK02100663.4A patent/HK1038889B/zh not_active IP Right Cessation
-
2003
- 2003-03-21 US US10/393,795 patent/US6852729B2/en not_active Expired - Lifetime
- 2003-08-25 NZ NZ527781A patent/NZ527781A/en not_active IP Right Cessation
-
2004
- 2004-12-23 US US11/020,860 patent/US7297703B2/en not_active Expired - Lifetime
-
2005
- 2005-02-28 AR ARP050100744A patent/AR048073A2/es active IP Right Grant
- 2005-04-01 JP JP2005106512A patent/JP5043308B2/ja not_active Expired - Lifetime
- 2005-12-28 JP JP2005378514A patent/JP5165199B2/ja not_active Expired - Lifetime
-
2006
- 2006-05-04 AR ARP060101807A patent/AR054444A2/es active IP Right Grant
-
2007
- 2007-09-14 CY CY20071101192T patent/CY1106870T1/el unknown
- 2007-10-11 US US11/973,927 patent/US7572804B2/en not_active Expired - Fee Related
-
2009
- 2009-07-06 US US12/497,728 patent/US7741338B2/en not_active Expired - Fee Related
-
2012
- 2012-10-01 NO NO20121113A patent/NO334612B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143092A0 (en) | Stabilization of macrolides | |
IL137024A0 (en) | Novel macrolides | |
PL341647A1 (en) | Novel derivatives of erythromycin | |
TW364383U (en) | Improvement on structure of wrist-ball | |
PL342733A1 (en) | Biocement of improved properties | |
SG83724A1 (en) | Novel polyene macrolide compounds and uses | |
TW399818U (en) | Structure of connector | |
HUP9902855A3 (en) | Preparation of sterol- and stanol-esters | |
AU2003200370A1 (en) | Stabilization of macrolides | |
TW371522U (en) | Card-rejection mechanism of connector | |
AU3898299A (en) | Thermal treatment wall | |
TW398188U (en) | Improved structure of de-hooker | |
TW354479U (en) | Improvement of earpick | |
GB2346031B (en) | Adaption of cabling | |
GB9914540D0 (en) | Colonicure or RKH colone | |
TW355988U (en) | Improved structure for inserting-hook of curtain | |
TW433622U (en) | Improved structure of plug | |
TW428810U (en) | Improved structure of plug | |
GB9820641D0 (en) | Stabilisation of peroxidases | |
GB9818178D0 (en) | Curtain walls | |
TW380759U (en) | Structure of extended plug | |
PL109021U1 (en) | Section of approximately u-shape | |
TW392981U (en) | Improvement of connector | |
GB9826768D0 (en) | Improvements relating to stabilising devices | |
TW413011U (en) | Improved structure of pillow |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXTN | Extension order renewed | ||
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |